These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 27764892)
41. Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance. Gaggini M; Carli F; Rosso C; Buzzigoli E; Marietti M; Della Latta V; Ciociaro D; Abate ML; Gambino R; Cassader M; Bugianesi E; Gastaldelli A Hepatology; 2018 Jan; 67(1):145-158. PubMed ID: 28802074 [TBL] [Abstract][Full Text] [Related]
42. Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance. Bastard JP; Piéroni L; Hainque B Diabetes Metab Res Rev; 2000; 16(3):192-201. PubMed ID: 10867719 [TBL] [Abstract][Full Text] [Related]
43. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. Pacifico L; Di Martino M; De Merulis A; Bezzi M; Osborn JF; Catalano C; Chiesa C Hepatology; 2014 Feb; 59(2):461-70. PubMed ID: 23843206 [TBL] [Abstract][Full Text] [Related]
44. Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease. Sakr HF; Abbas AM; Haidara MA J Basic Clin Physiol Pharmacol; 2018 Jan; 29(1):61-71. PubMed ID: 29161233 [TBL] [Abstract][Full Text] [Related]
45. Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circle. Alterio A; Alisi A; Liccardo D; Nobili V Horm Res Paediatr; 2014; 82(5):283-9. PubMed ID: 25324136 [TBL] [Abstract][Full Text] [Related]
46. Histopathology, grading and staging of nonalcoholic fatty liver disease. Kleiner DE Minerva Gastroenterol Dietol; 2018 Mar; 64(1):28-38. PubMed ID: 28948754 [TBL] [Abstract][Full Text] [Related]
47. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children. Kinik ST; Ozbek N; Yuce M; Yazici AC; Verdi H; Ataç FB Thromb Haemost; 2008 Feb; 99(2):352-6. PubMed ID: 18278185 [TBL] [Abstract][Full Text] [Related]
48. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children. El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627 [TBL] [Abstract][Full Text] [Related]
49. Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease. Horas H Nababan S; Nishiumi S; Kawano Y; Kobayashi T; Yoshida M; Azuma T Arch Biochem Biophys; 2017 Jun; 623-624():64-75. PubMed ID: 28456640 [TBL] [Abstract][Full Text] [Related]